Global Emphysema Treatment Market by Route of Administration (Oral, Parenteral, Inhalation), by Type (Panacinar, Centriacinar, Paraseptal), by Treatment (Therapy, Surgery, Medication), by Diagnosis (Lab Test, Imaging Test, Spirometry), by End User (Hospitals, Specialty Clinics) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028
Up Market Research published a new report titled “Emphysema Treatment Market research report which is segmented by Route of Administration (Oral, Parenteral, Inhalation), by Type (Panacinar, Centriacinar, Paraseptal), by Treatment (Therapy, Surgery, Medication), by Diagnosis (Lab Test, Imaging Test, Spirometry), by End User (Hospitals, Specialty Clinics), By Players/Companies OptiNose US Inc., Apotex Inc, Boehringer Ingelheim International GmbH, Mylan N.V, GlaxoSmithKline Plc, 3M, Amneal Pharmaceuticals LLC, Novartis AG, Intersect ENT, Merck Co. Inc, AstraZeneca, Teva Pharmaceutical Industries Ltd”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.
Report Scope
| Report Attributes | Report Details |
| Report Title | Emphysema Treatment Market Research Report |
| By Route of Administration | Oral, Parenteral, Inhalation |
| By Type | Panacinar, Centriacinar, Paraseptal |
| By Treatment | Therapy, Surgery, Medication |
| By Diagnosis | Lab Test, Imaging Test, Spirometry |
| By End User | Hospitals, Specialty Clinics |
| By Companies | OptiNose US Inc., Apotex Inc, Boehringer Ingelheim International GmbH, Mylan N.V, GlaxoSmithKline Plc, 3M, Amneal Pharmaceuticals LLC, Novartis AG, Intersect ENT, Merck Co. Inc, AstraZeneca, Teva Pharmaceutical Industries Ltd |
| Regions Covered | North America, Europe, APAC, Latin America, MEA |
| Base Year | 2020 |
| Historical Year | 2018 to 2019 (Data from 2010 can be provided as per availability) |
| Forecast Year | 2028 |
| Number of Pages | 227 |
| Number of Tables & Figures | 159 |
| Customization Available | Yes, the report can be customized as per your need. |
The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.
Global Emphysema Treatment Market Report Segments:
The market is segmented by Route of Administration (Oral, Parenteral, Inhalation), by Type (Panacinar, Centriacinar, Paraseptal), by Treatment (Therapy, Surgery, Medication), by Diagnosis (Lab Test, Imaging Test, Spirometry), by End User (Hospitals, Specialty Clinics).
Emphysema Treatment Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.
Key Benefits for Industry Participants & Stakeholders:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Emphysema Treatment Market
Overview of the regional outlook of the Emphysema Treatment Market:
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.
Highlights of The Emphysema Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of Emphysema Treatment Market.
- Historical data and forecast.
- Estimations for the forecast period 2028.
- Developments and trends in the market.
1. Oral
2. Parenteral
3. Inhalation
7. By Type:1. Panacinar
2. Centriacinar
3. Paraseptal
8. By Treatment:1. Therapy
2. Surgery
3. Medication
9. By Diagnosis:1. Lab Test
2. Imaging Test
3. Spirometry
10. By End User:1. Hospitals
2. Specialty Clinics
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Emphysema Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
Reasons to Purchase the Emphysema Treatment Market Report:
- The report includes a plethora of information such as market dynamics scenario and opportunities during the forecast period
- Segments and sub-segments include quantitative, qualitative, value (USD Million,) and volume (Units Million) data.
- Regional, sub-regional, and country level data includes the demand and supply forces along with their influence on the market.
- The competitive landscape comprises share of key players, new developments, and strategies in the last three years.
- Comprehensive companies offering products, relevant financial information, recent developments, SWOT analysis, and strategies by these players.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Emphysema Treatment Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Emphysema Treatment Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Emphysema Treatment Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Emphysema Treatment Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Emphysema Treatment Market Size & Forecast, 2018-2028
4.5.1 Emphysema Treatment Market Size and Y-o-Y Growth
4.5.2 Emphysema Treatment Market Absolute $ Opportunity
Chapter 5 Global Emphysema Treatment Market Analysis and Forecast by Route of Administration
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Route of Administration
5.1.2 Basis Point Share (BPS) Analysis by Route of Administration
5.1.3 Absolute $ Opportunity Assessment by Route of Administration
5.2 Emphysema Treatment Market Size Forecast by Route of Administration
5.2.1 Oral
5.2.2 Parenteral
5.2.3 Inhalation
5.3 Market Attractiveness Analysis by Route of Administration
Chapter 6 Global Emphysema Treatment Market Analysis and Forecast by Type
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Type
6.1.2 Basis Point Share (BPS) Analysis by Type
6.1.3 Absolute $ Opportunity Assessment by Type
6.2 Emphysema Treatment Market Size Forecast by Type
6.2.1 Panacinar
6.2.2 Centriacinar
6.2.3 Paraseptal
6.3 Market Attractiveness Analysis by Type
Chapter 7 Global Emphysema Treatment Market Analysis and Forecast by Treatment
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Treatment
7.1.2 Basis Point Share (BPS) Analysis by Treatment
7.1.3 Absolute $ Opportunity Assessment by Treatment
7.2 Emphysema Treatment Market Size Forecast by Treatment
7.2.1 Therapy
7.2.2 Surgery
7.2.3 Medication
7.3 Market Attractiveness Analysis by Treatment
Chapter 8 Global Emphysema Treatment Market Analysis and Forecast by Diagnosis
8.1 Introduction
8.1.1 Key Market Trends & Growth Opportunities by Diagnosis
8.1.2 Basis Point Share (BPS) Analysis by Diagnosis
8.1.3 Absolute $ Opportunity Assessment by Diagnosis
8.2 Emphysema Treatment Market Size Forecast by Diagnosis
8.2.1 Lab Test
8.2.2 Imaging Test
8.2.3 Spirometry
8.3 Market Attractiveness Analysis by Diagnosis
Chapter 9 Global Emphysema Treatment Market Analysis and Forecast by End User
9.1 Introduction
9.1.1 Key Market Trends & Growth Opportunities by End User
9.1.2 Basis Point Share (BPS) Analysis by End User
9.1.3 Absolute $ Opportunity Assessment by End User
9.2 Emphysema Treatment Market Size Forecast by End User
9.2.1 Hospitals
9.2.2 Specialty Clinics
9.3 Market Attractiveness Analysis by End User
Chapter 10 Global Emphysema Treatment Market Analysis and Forecast by Region
10.1 Introduction
10.1.1 Key Market Trends & Growth Opportunities by Region
10.1.2 Basis Point Share (BPS) Analysis by Region
10.1.3 Absolute $ Opportunity Assessment by Region
10.2 Emphysema Treatment Market Size Forecast by Region
10.2.1 North America
10.2.2 Europe
10.2.3 Asia Pacific
10.2.4 Latin America
10.2.5 Middle East & Africa (MEA)
10.3 Market Attractiveness Analysis by Region
Chapter 11 Coronavirus Disease (COVID-19) Impact
11.1 Introduction
11.2 Current & Future Impact Analysis
11.3 Economic Impact Analysis
11.4 Government Policies
11.5 Investment Scenario
Chapter 12 North America Emphysema Treatment Analysis and Forecast
12.1 Introduction
12.2 North America Emphysema Treatment Market Size Forecast by Country
12.2.1 U.S.
12.2.2 Canada
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 North America Emphysema Treatment Market Size Forecast by Route of Administration
12.6.1 Oral
12.6.2 Parenteral
12.6.3 Inhalation
12.7 Basis Point Share (BPS) Analysis by Route of Administration
12.8 Absolute $ Opportunity Assessment by Route of Administration
12.9 Market Attractiveness Analysis by Route of Administration
12.10 North America Emphysema Treatment Market Size Forecast by Type
12.10.1 Panacinar
12.10.2 Centriacinar
12.10.3 Paraseptal
12.11 Basis Point Share (BPS) Analysis by Type
12.12 Absolute $ Opportunity Assessment by Type
12.13 Market Attractiveness Analysis by Type
12.14 North America Emphysema Treatment Market Size Forecast by Treatment
12.14.1 Therapy
12.14.2 Surgery
12.14.3 Medication
12.15 Basis Point Share (BPS) Analysis by Treatment
12.16 Absolute $ Opportunity Assessment by Treatment
12.17 Market Attractiveness Analysis by Treatment
12.18 North America Emphysema Treatment Market Size Forecast by Diagnosis
12.18.1 Lab Test
12.18.2 Imaging Test
12.18.3 Spirometry
12.19 Basis Point Share (BPS) Analysis by Diagnosis
12.20 Absolute $ Opportunity Assessment by Diagnosis
12.21 Market Attractiveness Analysis by Diagnosis
12.22 North America Emphysema Treatment Market Size Forecast by End User
12.22.1 Hospitals
12.22.2 Specialty Clinics
12.23 Basis Point Share (BPS) Analysis by End User
12.24 Absolute $ Opportunity Assessment by End User
12.25 Market Attractiveness Analysis by End User
Chapter 13 Europe Emphysema Treatment Analysis and Forecast
13.1 Introduction
13.2 Europe Emphysema Treatment Market Size Forecast by Country
13.2.1 Germany
13.2.2 France
13.2.3 Italy
13.2.4 U.K.
13.2.5 Spain
13.2.6 Russia
13.2.7 Rest of Europe
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Europe Emphysema Treatment Market Size Forecast by Route of Administration
13.6.1 Oral
13.6.2 Parenteral
13.6.3 Inhalation
13.7 Basis Point Share (BPS) Analysis by Route of Administration
13.8 Absolute $ Opportunity Assessment by Route of Administration
13.9 Market Attractiveness Analysis by Route of Administration
13.10 Europe Emphysema Treatment Market Size Forecast by Type
13.10.1 Panacinar
13.10.2 Centriacinar
13.10.3 Paraseptal
13.11 Basis Point Share (BPS) Analysis by Type
13.12 Absolute $ Opportunity Assessment by Type
13.13 Market Attractiveness Analysis by Type
13.14 Europe Emphysema Treatment Market Size Forecast by Treatment
13.14.1 Therapy
13.14.2 Surgery
13.14.3 Medication
13.15 Basis Point Share (BPS) Analysis by Treatment
13.16 Absolute $ Opportunity Assessment by Treatment
13.17 Market Attractiveness Analysis by Treatment
13.18 Europe Emphysema Treatment Market Size Forecast by Diagnosis
13.18.1 Lab Test
13.18.2 Imaging Test
13.18.3 Spirometry
13.19 Basis Point Share (BPS) Analysis by Diagnosis
13.20 Absolute $ Opportunity Assessment by Diagnosis
13.21 Market Attractiveness Analysis by Diagnosis
13.22 Europe Emphysema Treatment Market Size Forecast by End User
13.22.1 Hospitals
13.22.2 Specialty Clinics
13.23 Basis Point Share (BPS) Analysis by End User
13.24 Absolute $ Opportunity Assessment by End User
13.25 Market Attractiveness Analysis by End User
Chapter 14 Asia Pacific Emphysema Treatment Analysis and Forecast
14.1 Introduction
14.2 Asia Pacific Emphysema Treatment Market Size Forecast by Country
14.2.1 China
14.2.2 Japan
14.2.3 South Korea
14.2.4 India
14.2.5 Australia
14.2.6 South East Asia (SEA)
14.2.7 Rest of Asia Pacific (APAC)
14.3 Basis Point Share (BPS) Analysis by Country
14.4 Absolute $ Opportunity Assessment by Country
14.5 Market Attractiveness Analysis by Country
14.6 Asia Pacific Emphysema Treatment Market Size Forecast by Route of Administration
14.6.1 Oral
14.6.2 Parenteral
14.6.3 Inhalation
14.7 Basis Point Share (BPS) Analysis by Route of Administration
14.8 Absolute $ Opportunity Assessment by Route of Administration
14.9 Market Attractiveness Analysis by Route of Administration
14.10 Asia Pacific Emphysema Treatment Market Size Forecast by Type
14.10.1 Panacinar
14.10.2 Centriacinar
14.10.3 Paraseptal
14.11 Basis Point Share (BPS) Analysis by Type
14.12 Absolute $ Opportunity Assessment by Type
14.13 Market Attractiveness Analysis by Type
14.14 Asia Pacific Emphysema Treatment Market Size Forecast by Treatment
14.14.1 Therapy
14.14.2 Surgery
14.14.3 Medication
14.15 Basis Point Share (BPS) Analysis by Treatment
14.16 Absolute $ Opportunity Assessment by Treatment
14.17 Market Attractiveness Analysis by Treatment
14.18 Asia Pacific Emphysema Treatment Market Size Forecast by Diagnosis
14.18.1 Lab Test
14.18.2 Imaging Test
14.18.3 Spirometry
14.19 Basis Point Share (BPS) Analysis by Diagnosis
14.20 Absolute $ Opportunity Assessment by Diagnosis
14.21 Market Attractiveness Analysis by Diagnosis
14.22 Asia Pacific Emphysema Treatment Market Size Forecast by End User
14.22.1 Hospitals
14.22.2 Specialty Clinics
14.23 Basis Point Share (BPS) Analysis by End User
14.24 Absolute $ Opportunity Assessment by End User
14.25 Market Attractiveness Analysis by End User
Chapter 15 Latin America Emphysema Treatment Analysis and Forecast
15.1 Introduction
15.2 Latin America Emphysema Treatment Market Size Forecast by Country
15.2.1 Brazil
15.2.2 Mexico
15.2.3 Rest of Latin America (LATAM)
15.3 Basis Point Share (BPS) Analysis by Country
15.4 Absolute $ Opportunity Assessment by Country
15.5 Market Attractiveness Analysis by Country
15.6 Latin America Emphysema Treatment Market Size Forecast by Route of Administration
15.6.1 Oral
15.6.2 Parenteral
15.6.3 Inhalation
15.7 Basis Point Share (BPS) Analysis by Route of Administration
15.8 Absolute $ Opportunity Assessment by Route of Administration
15.9 Market Attractiveness Analysis by Route of Administration
15.10 Latin America Emphysema Treatment Market Size Forecast by Type
15.10.1 Panacinar
15.10.2 Centriacinar
15.10.3 Paraseptal
15.11 Basis Point Share (BPS) Analysis by Type
15.12 Absolute $ Opportunity Assessment by Type
15.13 Market Attractiveness Analysis by Type
15.14 Latin America Emphysema Treatment Market Size Forecast by Treatment
15.14.1 Therapy
15.14.2 Surgery
15.14.3 Medication
15.15 Basis Point Share (BPS) Analysis by Treatment
15.16 Absolute $ Opportunity Assessment by Treatment
15.17 Market Attractiveness Analysis by Treatment
15.18 Latin America Emphysema Treatment Market Size Forecast by Diagnosis
15.18.1 Lab Test
15.18.2 Imaging Test
15.18.3 Spirometry
15.19 Basis Point Share (BPS) Analysis by Diagnosis
15.20 Absolute $ Opportunity Assessment by Diagnosis
15.21 Market Attractiveness Analysis by Diagnosis
15.22 Latin America Emphysema Treatment Market Size Forecast by End User
15.22.1 Hospitals
15.22.2 Specialty Clinics
15.23 Basis Point Share (BPS) Analysis by End User
15.24 Absolute $ Opportunity Assessment by End User
15.25 Market Attractiveness Analysis by End User
Chapter 16 Middle East & Africa (MEA) Emphysema Treatment Analysis and Forecast
16.1 Introduction
16.2 Middle East & Africa (MEA) Emphysema Treatment Market Size Forecast by Country
16.2.1 Saudi Arabia
16.2.2 South Africa
16.2.3 UAE
16.2.4 Rest of Middle East & Africa (MEA)
16.3 Basis Point Share (BPS) Analysis by Country
16.4 Absolute $ Opportunity Assessment by Country
16.5 Market Attractiveness Analysis by Country
16.6 Middle East & Africa (MEA) Emphysema Treatment Market Size Forecast by Route of Administration
16.6.1 Oral
16.6.2 Parenteral
16.6.3 Inhalation
16.7 Basis Point Share (BPS) Analysis by Route of Administration
16.8 Absolute $ Opportunity Assessment by Route of Administration
16.9 Market Attractiveness Analysis by Route of Administration
16.10 Middle East & Africa (MEA) Emphysema Treatment Market Size Forecast by Type
16.10.1 Panacinar
16.10.2 Centriacinar
16.10.3 Paraseptal
16.11 Basis Point Share (BPS) Analysis by Type
16.12 Absolute $ Opportunity Assessment by Type
16.13 Market Attractiveness Analysis by Type
16.14 Middle East & Africa (MEA) Emphysema Treatment Market Size Forecast by Treatment
16.14.1 Therapy
16.14.2 Surgery
16.14.3 Medication
16.15 Basis Point Share (BPS) Analysis by Treatment
16.16 Absolute $ Opportunity Assessment by Treatment
16.17 Market Attractiveness Analysis by Treatment
16.18 Middle East & Africa (MEA) Emphysema Treatment Market Size Forecast by Diagnosis
16.18.1 Lab Test
16.18.2 Imaging Test
16.18.3 Spirometry
16.19 Basis Point Share (BPS) Analysis by Diagnosis
16.20 Absolute $ Opportunity Assessment by Diagnosis
16.21 Market Attractiveness Analysis by Diagnosis
16.22 Middle East & Africa (MEA) Emphysema Treatment Market Size Forecast by End User
16.22.1 Hospitals
16.22.2 Specialty Clinics
16.23 Basis Point Share (BPS) Analysis by End User
16.24 Absolute $ Opportunity Assessment by End User
16.25 Market Attractiveness Analysis by End User
Chapter 17 Competition Landscape
17.1 Emphysema Treatment Market: Competitive Dashboard
17.2 Global Emphysema Treatment Market: Market Share Analysis, 2019
17.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
17.3.1 OptiNose US Inc.
17.3.2 Apotex Inc
17.3.3 Boehringer Ingelheim International GmbH
17.3.4 Mylan N.V
17.3.5 GlaxoSmithKline Plc
17.3.6 3M
17.3.7 Amneal Pharmaceuticals LLC
17.3.8 Novartis AG
17.3.9 Intersect ENT
17.3.10 Merck Co. Inc
17.3.11 AstraZeneca
17.3.12 Teva Pharmaceutical Industries Ltd
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Emphysema Treatment Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Emphysema Treatment Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Emphysema Treatment Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Emphysema Treatment Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Emphysema Treatment Market Size & Forecast, 2018-2028
4.5.1 Emphysema Treatment Market Size and Y-o-Y Growth
4.5.2 Emphysema Treatment Market Absolute $ Opportunity
Chapter 5 Global Emphysema Treatment Market Analysis and Forecast by Route of Administration
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Route of Administration
5.1.2 Basis Point Share (BPS) Analysis by Route of Administration
5.1.3 Absolute $ Opportunity Assessment by Route of Administration
5.2 Emphysema Treatment Market Size Forecast by Route of Administration
5.2.1 Oral
5.2.2 Parenteral
5.2.3 Inhalation
5.3 Market Attractiveness Analysis by Route of Administration
Chapter 6 Global Emphysema Treatment Market Analysis and Forecast by Type
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Type
6.1.2 Basis Point Share (BPS) Analysis by Type
6.1.3 Absolute $ Opportunity Assessment by Type
6.2 Emphysema Treatment Market Size Forecast by Type
6.2.1 Panacinar
6.2.2 Centriacinar
6.2.3 Paraseptal
6.3 Market Attractiveness Analysis by Type
Chapter 7 Global Emphysema Treatment Market Analysis and Forecast by Treatment
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Treatment
7.1.2 Basis Point Share (BPS) Analysis by Treatment
7.1.3 Absolute $ Opportunity Assessment by Treatment
7.2 Emphysema Treatment Market Size Forecast by Treatment
7.2.1 Therapy
7.2.2 Surgery
7.2.3 Medication
7.3 Market Attractiveness Analysis by Treatment
Chapter 8 Global Emphysema Treatment Market Analysis and Forecast by Diagnosis
8.1 Introduction
8.1.1 Key Market Trends & Growth Opportunities by Diagnosis
8.1.2 Basis Point Share (BPS) Analysis by Diagnosis
8.1.3 Absolute $ Opportunity Assessment by Diagnosis
8.2 Emphysema Treatment Market Size Forecast by Diagnosis
8.2.1 Lab Test
8.2.2 Imaging Test
8.2.3 Spirometry
8.3 Market Attractiveness Analysis by Diagnosis
Chapter 9 Global Emphysema Treatment Market Analysis and Forecast by End User
9.1 Introduction
9.1.1 Key Market Trends & Growth Opportunities by End User
9.1.2 Basis Point Share (BPS) Analysis by End User
9.1.3 Absolute $ Opportunity Assessment by End User
9.2 Emphysema Treatment Market Size Forecast by End User
9.2.1 Hospitals
9.2.2 Specialty Clinics
9.3 Market Attractiveness Analysis by End User
Chapter 10 Global Emphysema Treatment Market Analysis and Forecast by Region
10.1 Introduction
10.1.1 Key Market Trends & Growth Opportunities by Region
10.1.2 Basis Point Share (BPS) Analysis by Region
10.1.3 Absolute $ Opportunity Assessment by Region
10.2 Emphysema Treatment Market Size Forecast by Region
10.2.1 North America
10.2.2 Europe
10.2.3 Asia Pacific
10.2.4 Latin America
10.2.5 Middle East & Africa (MEA)
10.3 Market Attractiveness Analysis by Region
Chapter 11 Coronavirus Disease (COVID-19) Impact
11.1 Introduction
11.2 Current & Future Impact Analysis
11.3 Economic Impact Analysis
11.4 Government Policies
11.5 Investment Scenario
Chapter 12 North America Emphysema Treatment Analysis and Forecast
12.1 Introduction
12.2 North America Emphysema Treatment Market Size Forecast by Country
12.2.1 U.S.
12.2.2 Canada
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 North America Emphysema Treatment Market Size Forecast by Route of Administration
12.6.1 Oral
12.6.2 Parenteral
12.6.3 Inhalation
12.7 Basis Point Share (BPS) Analysis by Route of Administration
12.8 Absolute $ Opportunity Assessment by Route of Administration
12.9 Market Attractiveness Analysis by Route of Administration
12.10 North America Emphysema Treatment Market Size Forecast by Type
12.10.1 Panacinar
12.10.2 Centriacinar
12.10.3 Paraseptal
12.11 Basis Point Share (BPS) Analysis by Type
12.12 Absolute $ Opportunity Assessment by Type
12.13 Market Attractiveness Analysis by Type
12.14 North America Emphysema Treatment Market Size Forecast by Treatment
12.14.1 Therapy
12.14.2 Surgery
12.14.3 Medication
12.15 Basis Point Share (BPS) Analysis by Treatment
12.16 Absolute $ Opportunity Assessment by Treatment
12.17 Market Attractiveness Analysis by Treatment
12.18 North America Emphysema Treatment Market Size Forecast by Diagnosis
12.18.1 Lab Test
12.18.2 Imaging Test
12.18.3 Spirometry
12.19 Basis Point Share (BPS) Analysis by Diagnosis
12.20 Absolute $ Opportunity Assessment by Diagnosis
12.21 Market Attractiveness Analysis by Diagnosis
12.22 North America Emphysema Treatment Market Size Forecast by End User
12.22.1 Hospitals
12.22.2 Specialty Clinics
12.23 Basis Point Share (BPS) Analysis by End User
12.24 Absolute $ Opportunity Assessment by End User
12.25 Market Attractiveness Analysis by End User
Chapter 13 Europe Emphysema Treatment Analysis and Forecast
13.1 Introduction
13.2 Europe Emphysema Treatment Market Size Forecast by Country
13.2.1 Germany
13.2.2 France
13.2.3 Italy
13.2.4 U.K.
13.2.5 Spain
13.2.6 Russia
13.2.7 Rest of Europe
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Europe Emphysema Treatment Market Size Forecast by Route of Administration
13.6.1 Oral
13.6.2 Parenteral
13.6.3 Inhalation
13.7 Basis Point Share (BPS) Analysis by Route of Administration
13.8 Absolute $ Opportunity Assessment by Route of Administration
13.9 Market Attractiveness Analysis by Route of Administration
13.10 Europe Emphysema Treatment Market Size Forecast by Type
13.10.1 Panacinar
13.10.2 Centriacinar
13.10.3 Paraseptal
13.11 Basis Point Share (BPS) Analysis by Type
13.12 Absolute $ Opportunity Assessment by Type
13.13 Market Attractiveness Analysis by Type
13.14 Europe Emphysema Treatment Market Size Forecast by Treatment
13.14.1 Therapy
13.14.2 Surgery
13.14.3 Medication
13.15 Basis Point Share (BPS) Analysis by Treatment
13.16 Absolute $ Opportunity Assessment by Treatment
13.17 Market Attractiveness Analysis by Treatment
13.18 Europe Emphysema Treatment Market Size Forecast by Diagnosis
13.18.1 Lab Test
13.18.2 Imaging Test
13.18.3 Spirometry
13.19 Basis Point Share (BPS) Analysis by Diagnosis
13.20 Absolute $ Opportunity Assessment by Diagnosis
13.21 Market Attractiveness Analysis by Diagnosis
13.22 Europe Emphysema Treatment Market Size Forecast by End User
13.22.1 Hospitals
13.22.2 Specialty Clinics
13.23 Basis Point Share (BPS) Analysis by End User
13.24 Absolute $ Opportunity Assessment by End User
13.25 Market Attractiveness Analysis by End User
Chapter 14 Asia Pacific Emphysema Treatment Analysis and Forecast
14.1 Introduction
14.2 Asia Pacific Emphysema Treatment Market Size Forecast by Country
14.2.1 China
14.2.2 Japan
14.2.3 South Korea
14.2.4 India
14.2.5 Australia
14.2.6 South East Asia (SEA)
14.2.7 Rest of Asia Pacific (APAC)
14.3 Basis Point Share (BPS) Analysis by Country
14.4 Absolute $ Opportunity Assessment by Country
14.5 Market Attractiveness Analysis by Country
14.6 Asia Pacific Emphysema Treatment Market Size Forecast by Route of Administration
14.6.1 Oral
14.6.2 Parenteral
14.6.3 Inhalation
14.7 Basis Point Share (BPS) Analysis by Route of Administration
14.8 Absolute $ Opportunity Assessment by Route of Administration
14.9 Market Attractiveness Analysis by Route of Administration
14.10 Asia Pacific Emphysema Treatment Market Size Forecast by Type
14.10.1 Panacinar
14.10.2 Centriacinar
14.10.3 Paraseptal
14.11 Basis Point Share (BPS) Analysis by Type
14.12 Absolute $ Opportunity Assessment by Type
14.13 Market Attractiveness Analysis by Type
14.14 Asia Pacific Emphysema Treatment Market Size Forecast by Treatment
14.14.1 Therapy
14.14.2 Surgery
14.14.3 Medication
14.15 Basis Point Share (BPS) Analysis by Treatment
14.16 Absolute $ Opportunity Assessment by Treatment
14.17 Market Attractiveness Analysis by Treatment
14.18 Asia Pacific Emphysema Treatment Market Size Forecast by Diagnosis
14.18.1 Lab Test
14.18.2 Imaging Test
14.18.3 Spirometry
14.19 Basis Point Share (BPS) Analysis by Diagnosis
14.20 Absolute $ Opportunity Assessment by Diagnosis
14.21 Market Attractiveness Analysis by Diagnosis
14.22 Asia Pacific Emphysema Treatment Market Size Forecast by End User
14.22.1 Hospitals
14.22.2 Specialty Clinics
14.23 Basis Point Share (BPS) Analysis by End User
14.24 Absolute $ Opportunity Assessment by End User
14.25 Market Attractiveness Analysis by End User
Chapter 15 Latin America Emphysema Treatment Analysis and Forecast
15.1 Introduction
15.2 Latin America Emphysema Treatment Market Size Forecast by Country
15.2.1 Brazil
15.2.2 Mexico
15.2.3 Rest of Latin America (LATAM)
15.3 Basis Point Share (BPS) Analysis by Country
15.4 Absolute $ Opportunity Assessment by Country
15.5 Market Attractiveness Analysis by Country
15.6 Latin America Emphysema Treatment Market Size Forecast by Route of Administration
15.6.1 Oral
15.6.2 Parenteral
15.6.3 Inhalation
15.7 Basis Point Share (BPS) Analysis by Route of Administration
15.8 Absolute $ Opportunity Assessment by Route of Administration
15.9 Market Attractiveness Analysis by Route of Administration
15.10 Latin America Emphysema Treatment Market Size Forecast by Type
15.10.1 Panacinar
15.10.2 Centriacinar
15.10.3 Paraseptal
15.11 Basis Point Share (BPS) Analysis by Type
15.12 Absolute $ Opportunity Assessment by Type
15.13 Market Attractiveness Analysis by Type
15.14 Latin America Emphysema Treatment Market Size Forecast by Treatment
15.14.1 Therapy
15.14.2 Surgery
15.14.3 Medication
15.15 Basis Point Share (BPS) Analysis by Treatment
15.16 Absolute $ Opportunity Assessment by Treatment
15.17 Market Attractiveness Analysis by Treatment
15.18 Latin America Emphysema Treatment Market Size Forecast by Diagnosis
15.18.1 Lab Test
15.18.2 Imaging Test
15.18.3 Spirometry
15.19 Basis Point Share (BPS) Analysis by Diagnosis
15.20 Absolute $ Opportunity Assessment by Diagnosis
15.21 Market Attractiveness Analysis by Diagnosis
15.22 Latin America Emphysema Treatment Market Size Forecast by End User
15.22.1 Hospitals
15.22.2 Specialty Clinics
15.23 Basis Point Share (BPS) Analysis by End User
15.24 Absolute $ Opportunity Assessment by End User
15.25 Market Attractiveness Analysis by End User
Chapter 16 Middle East & Africa (MEA) Emphysema Treatment Analysis and Forecast
16.1 Introduction
16.2 Middle East & Africa (MEA) Emphysema Treatment Market Size Forecast by Country
16.2.1 Saudi Arabia
16.2.2 South Africa
16.2.3 UAE
16.2.4 Rest of Middle East & Africa (MEA)
16.3 Basis Point Share (BPS) Analysis by Country
16.4 Absolute $ Opportunity Assessment by Country
16.5 Market Attractiveness Analysis by Country
16.6 Middle East & Africa (MEA) Emphysema Treatment Market Size Forecast by Route of Administration
16.6.1 Oral
16.6.2 Parenteral
16.6.3 Inhalation
16.7 Basis Point Share (BPS) Analysis by Route of Administration
16.8 Absolute $ Opportunity Assessment by Route of Administration
16.9 Market Attractiveness Analysis by Route of Administration
16.10 Middle East & Africa (MEA) Emphysema Treatment Market Size Forecast by Type
16.10.1 Panacinar
16.10.2 Centriacinar
16.10.3 Paraseptal
16.11 Basis Point Share (BPS) Analysis by Type
16.12 Absolute $ Opportunity Assessment by Type
16.13 Market Attractiveness Analysis by Type
16.14 Middle East & Africa (MEA) Emphysema Treatment Market Size Forecast by Treatment
16.14.1 Therapy
16.14.2 Surgery
16.14.3 Medication
16.15 Basis Point Share (BPS) Analysis by Treatment
16.16 Absolute $ Opportunity Assessment by Treatment
16.17 Market Attractiveness Analysis by Treatment
16.18 Middle East & Africa (MEA) Emphysema Treatment Market Size Forecast by Diagnosis
16.18.1 Lab Test
16.18.2 Imaging Test
16.18.3 Spirometry
16.19 Basis Point Share (BPS) Analysis by Diagnosis
16.20 Absolute $ Opportunity Assessment by Diagnosis
16.21 Market Attractiveness Analysis by Diagnosis
16.22 Middle East & Africa (MEA) Emphysema Treatment Market Size Forecast by End User
16.22.1 Hospitals
16.22.2 Specialty Clinics
16.23 Basis Point Share (BPS) Analysis by End User
16.24 Absolute $ Opportunity Assessment by End User
16.25 Market Attractiveness Analysis by End User
Chapter 17 Competition Landscape
17.1 Emphysema Treatment Market: Competitive Dashboard
17.2 Global Emphysema Treatment Market: Market Share Analysis, 2019
17.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
17.3.1 OptiNose US Inc.
17.3.2 Apotex Inc
17.3.3 Boehringer Ingelheim International GmbH
17.3.4 Mylan N.V
17.3.5 GlaxoSmithKline Plc
17.3.6 3M
17.3.7 Amneal Pharmaceuticals LLC
17.3.8 Novartis AG
17.3.9 Intersect ENT
17.3.10 Merck Co. Inc
17.3.11 AstraZeneca
17.3.12 Teva Pharmaceutical Industries Ltd
Segments Covered in the Report
The global Emphysema Treatment market has been segmented based on
By Route of Administration
The global Emphysema Treatment market has been segmented based on
By Route of Administration
- Oral
- Parenteral
- Inhalation
- Panacinar
- Centriacinar
- Paraseptal
- Therapy
- Surgery
- Medication
- Lab Test
- Imaging Test
- Spirometry
- Hospitals
- Specialty Clinics
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
- OptiNose US Inc.
- Apotex Inc
- Boehringer Ingelheim International GmbH
- Mylan N.V
- GlaxoSmithKline Plc
- 3M
- Amneal Pharmaceuticals LLC
- Novartis AG
- Intersect ENT
- Merck Co. Inc
- AstraZeneca
- Teva Pharmaceutical Industries Ltd
Our Clients
Related Reports
Some other reports from this category!
